skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,091  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Lipids remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Addressing dyslipidemic risk beyond LDL-cholesterol
Material Type:
Article
Add to My Research

Addressing dyslipidemic risk beyond LDL-cholesterol

The Journal of clinical investigation, 2022-01, Vol.132 (1), p.1-10 [Peer Reviewed Journal]

COPYRIGHT 2022 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Jan 2022 ;2022 Tall et al. 2022 Tall et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI148559 ;PMID: 34981790

Full text available

2
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Material Type:
Article
Add to My Research

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

Nature biotechnology, 2021-08, Vol.39 (8), p.949-957 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1087-0156 ;EISSN: 1546-1696 ;DOI: 10.1038/s41587-021-00933-4 ;PMID: 34012094

Full text available

3
A robust and efficient method for Mendelian randomization with hundreds of genetic variants
Material Type:
Article
Add to My Research

A robust and efficient method for Mendelian randomization with hundreds of genetic variants

Nature communications, 2020-01, Vol.11 (1), p.376-376, Article 376 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-14156-4 ;PMID: 31953392

Full text available

4
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Material Type:
Article
Add to My Research

Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis

PLoS medicine, 2020-03, Vol.17 (3), p.e1003062-e1003062 [Peer Reviewed Journal]

2020 Richardson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Richardson et al 2020 Richardson et al ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/JOURNAL.PMED.1003062 ;PMID: 32203549

Full text available

5
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Material Type:
Article
Add to My Research

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

The Lancet (British edition), 2017-10, Vol.390 (10106), p.1962-1971 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 28, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32290-0 ;PMID: 28859947

Full text available

6
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents
Material Type:
Article
Add to My Research

2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Journal of the American College of Cardiology, 2016-07, Vol.68 (1), p.92-125 [Peer Reviewed Journal]

Copyright Elsevier Limited Jul 5, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.03.519 ;PMID: 27046161

Full text available

7
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Material Type:
Article
Add to My Research

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

The New England journal of medicine, 2019-03, Vol.380 (11), p.1022-1032 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1803917 ;PMID: 30865796

Full text available

8
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology
Material Type:
Article
Add to My Research

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

Circulation research, 2016-02, Vol.118 (4), p.547-563 [Peer Reviewed Journal]

2016 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.115.306249 ;PMID: 26892957

Full text available

9
Discovery and refinement of loci associated with lipid levels
Material Type:
Article
Add to My Research

Discovery and refinement of loci associated with lipid levels

Nature genetics, 2013-11, Vol.45 (11), p.1274-1283 [Peer Reviewed Journal]

COPYRIGHT 2013 Nature Publishing Group ;COPYRIGHT 2013 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2013 ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/ng.2797 ;PMID: 24097068

Full text available

10
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Material Type:
Article
Add to My Research

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

The New England journal of medicine, 2015-04, Vol.372 (16), p.1489-1499 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1501031 ;PMID: 25773378

Full text available

11
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Material Type:
Article
Add to My Research

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

The New England journal of medicine, 2015-04, Vol.372 (16), p.1500-1509 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1500858 ;PMID: 25773607

Full text available

12
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Material Type:
Article
Add to My Research

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

The Lancet (British edition), 2021-11, Vol.398 (10312), p.1713-1725 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01122-3 ;PMID: 34506743

Full text available

13
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-01, Vol.385 (9965), p.331-340 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 24, 2015 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61399-4 ;PMID: 25282519 ;CODEN: LANCAO

Full text available

14
Common variants associated with plasma triglycerides and risk for coronary artery disease
Material Type:
Article
Add to My Research

Common variants associated with plasma triglycerides and risk for coronary artery disease

Nature genetics, 2013-11, Vol.45 (11), p.1345-1352 [Peer Reviewed Journal]

COPYRIGHT 2013 Nature Publishing Group ;COPYRIGHT 2013 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2013 ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/ng.2795 ;PMID: 24097064

Full text available

15
Mendelian Randomization Study of ACLY and Cardiovascular Disease
Material Type:
Article
Add to My Research

Mendelian Randomization Study of ACLY and Cardiovascular Disease

The New England journal of medicine, 2019-03, Vol.380 (11), p.1033-1042 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1806747 ;PMID: 30865797

Full text available

16
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
Material Type:
Article
Add to My Research

Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation

Clinical chemistry (Baltimore, Md.), 2021-01, Vol.67 (1), p.143-153 [Peer Reviewed Journal]

American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2020 ;American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;COPYRIGHT 2021 American Association for Clinical Chemistry, Inc. ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1093/clinchem/hvaa252 ;PMID: 33257928

Full text available

17
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
Material Type:
Article
Add to My Research

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

The Lancet (British edition), 2014-01, Vol.383 (9911), p.60-68 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 4, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)61914-5 ;PMID: 24094767 ;CODEN: LANCAO

Full text available

18
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
Material Type:
Article
Add to My Research

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study

The Lancet (British edition), 2013-04, Vol.381 (9874), p.1293-1301 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 13, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)62127-8 ;PMID: 23433573 ;CODEN: LANCAO

Full text available

19
Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
Material Type:
Article
Add to My Research

Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk

Nature genetics, 2014-04, Vol.46 (4), p.345-351 [Peer Reviewed Journal]

COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2014 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/ng.2926 ;PMID: 24633158

Full text available

20
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up
Material Type:
Article
Add to My Research

Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up

Circulation (New York, N.Y.), 2017-11, Vol.136 (20), p.1878-1891 [Peer Reviewed Journal]

2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.027966 ;PMID: 28877913

Full text available

Results 1 - 20 of 3,091  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2,997)

Refine My Results

Creation Date 

From To
  1. Before 1990  (69)
  2. 1990 To 1997  (179)
  3. 1998 To 2005  (465)
  4. 2006 To 2014  (855)
  5. After 2014  (1,524)
  6. More options open sub menu

Resource Type 

  1. Articles  (3,083)
  2. magazinearticle  (6)
  3. Books  (2)
  4. More options open sub menu

Language 

  1. English  (3,087)
  2. Japanese  (461)
  3. Portuguese  (8)
  4. Norwegian  (6)
  5. Chinese  (4)
  6. Polish  (3)
  7. Turkish  (2)
  8. Russian  (1)
  9. Croatian  (1)
  10. Dutch  (1)
  11. More options open sub menu

Searching Remote Databases, Please Wait